peptide sciences glp 1 Diagram of how GLP-1 glucagon-like pep | Stock Image GLP-1 vs. Peptide Therapy: What's

Description

The dual mechanism does not appear to reduce the gastroparesis risk

Schernthaner G, et al

Some analyses show a reduced risk of pulmonary embolism with GLP-1 use, while one 2025 meta-analysis found a significantly higher DVT risk in patients who had been on these medications for more than 78 weeks

Frequently Asked Questions What makes Shotsy a better alternative to Glippy

Nutritional Priorities to Support GLP1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society